Exploring environmental modifiers of LRRK2-associated Parkinson's disease penetrance: An exposomics and metagenomics pilot study on household dust

被引:0
|
作者
Andujar, Begona Talavera [1 ]
Pereira, Sandro L. [1 ]
Busi, Susheel Bhanu [1 ,2 ]
Usnich, Tatiana [3 ]
Borsche, Max [3 ,4 ]
Ertan, Sibel [5 ]
Bauer, Peter [6 ]
Rolfs, Arndt [6 ]
Hezzaz, Soraya [1 ]
Ghelfi, Jenny [1 ]
Brueggemann, Norbert [3 ,4 ]
Antony, Paul [1 ]
Wilmes, Paul [1 ,7 ]
Klein, Christine [3 ]
Gruenewald, Anne [1 ]
Schymanski, Emma L. [1 ]
机构
[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, L-4367 Belvaux, Luxembourg
[2] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England
[3] Univ Lubeck, Inst Neurogenet, Lubeck, Germany
[4] Univ Lubeck, Dept Neurol, Lubeck, Germany
[5] Koc Univ, Sch Med, Dept Neurol, Istanbul, Turkiye
[6] CENTOGENE GmbH, Rostock, Germany
[7] Univ Luxembourg, Fac Sci Technol & Med, Dept Life Sci & Med, L-4362 Esch Sur Alzette, Luxembourg
关键词
Indoor environment; Exposomics; Metagenomics; Parkinson's disease; Leucine-rich repeat kinase 2 (LRRK2); Bisphenol S; MASS-SPECTROMETRY; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PIPECOLIC ACID; IN-VITRO; MANAGEMENT; RELEVANCE; FIPRONIL; BACTERIA;
D O I
10.1016/j.envint.2024.109151
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Pathogenic variants in the Leucine-rich repeat kinase 2 (LRRK2) gene are a primary monogenic cause of Parkinson's disease (PD). However, the likelihood of developing PD with inherited LRRK2 pathogenic variants differs (a phenomenon known as "reduced penetrance"), with factors including age and geographic region, highlighting a potential role for lifestyle and environmental factors in disease onset. To investigate this, household dust samples from four different groups of individuals were analyzed using metabolomics/exposomics and metagenomics approaches: PD+/LRRK2+ (PD patients with pathogenic LRRK2 variants; n = 11), PD-/LRRK2+ (individuals with pathogenic LRRK2 variants but without PD diagnosis; n = 8), iPD (PD of unknown cause; n = 11), and a matched, healthy control group (n = 11). The dust was complemented with metabolomics and lipidomics of matched serum samples, where available. A total of 1,003 chemicals and 163 metagenomic operational taxonomic units (mOTUs) were identified in the dust samples, of which ninety chemicals and ten mOTUs were statistically significant (ANOVA p-value < 0.05). Reduced levels of 2-benzothiazolesulfonic acid (BThSO3) were found in the PD-/LRRK2+ group compared to the PD+/LRRK2+ . Among the significant chemicals tentatively identified in dust, two are hazardous chemical replacements: Bisphenol S (BPS), and perfluorobutane sulfonic acid (PFBuS). Furthermore, various lipids were found altered in serum including different lysophosphatidylethanolamines (LPEs), and lysophosphatidylcholines (LPCs), some with higher levels in the PD+/LRRK2+ group compared to the control group. A cellular study on isogenic neurons generated from a PD+/LRRK2+ patient demonstrated that BPS negatively impacts mitochondrial function, which is implicated in PD pathogenesis. This pilot study demonstrates how non-target metabolomics/exposomics analysis of indoor dust samples complemented with metagenomics can prioritize relevant chemicals that may be potential modifiers of LRRK2 penetrance.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Molecular mechanisms defining penetrance of LRRK2-associated Parkinson's disease
    Trinh, Joanne
    Schymanski, Emma L.
    Smajic, Semra
    Kasten, Meike
    Sammler, Esther
    Gruenewald, Anne
    MEDIZINISCHE GENETIK, 2022, 34 (02) : 103 - 116
  • [2] Clinical features of LRRK2-associated Parkinson's disease
    Pchelina, S. N.
    Ivanova, O. N.
    Emelyanov, A. K.
    Yakimovskii, A. F.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2011, 111 (12) : 56 - 62
  • [3] Motor Phenotype of LRRK2-Associated Parkinson's Disease: A Tunisian Longitudinal Study
    Nabli, Fatma
    Ben Sassi, Samia
    Amouri, Rim
    Duda, John E.
    Farrer, Matthew J.
    Hentati, Faycal
    MOVEMENT DISORDERS, 2015, 30 (02) : 253 - 258
  • [4] Microarray expression analysis in idiopathic and LRRK2-associated Parkinson's disease
    Botta-Orfila, Teresa
    Tolosa, Eduard
    Gelpi, Ellen
    Sanchez-Pla, Alex
    Marti, Maria-Jose
    Valldeoriola, Francesc
    Fernandez, Mane
    Carmona, Francesc
    Ezquerra, Mario
    NEUROBIOLOGY OF DISEASE, 2012, 45 (01) : 462 - 468
  • [5] Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease
    Botta-Orfila, Teresa
    Sanchez-Pla, Alex
    Fernandez, Manel
    Carmona, Francesc
    Ezquerra, Mario
    Tolosa, Eduard
    BRAIN RESEARCH, 2012, 1466 : 152 - 157
  • [6] Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease
    Fernandez-Pajarin, G.
    Sesar, A.
    Jimenez-Martin, I.
    Castro, B.
    Castro, A.
    NEUROLOGIA, 2023, 38 (05): : 350 - 356
  • [7] Apoptosis of peripheral blood lymphocytes in patients with LRRK2-associated Parkinson's disease
    T. S. Usenko
    A. K. Emelyanov
    A. F. Yakimovskii
    N. A. Bogankova
    T. V. Vavilova
    A. L. Schwarzman
    S. N. Pchelina
    Cell and Tissue Biology, 2012, 6 (2) : 171 - 175
  • [8] LRRK2-associated Parkinson's disease patients have better stereopsis than idiopathic Parkinson disease
    Sun, Liang
    Chan, Piu
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 169 : 174 - 177
  • [9] Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease
    Weykopf, Beatrice
    Haupt, Simone
    Jungverdorben, Johannes
    Flitsch, Lea Jessica
    Hebisch, Matthias
    Liu, Guang-Hui
    Suzuki, Keiichiro
    Belmonte, Juan Carlos Izpisua
    Peitz, Michael
    Blaess, Sandra
    Till, Andreas
    Bruestle, Oliver
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (04) : 561 - 589
  • [10] Genomewide Linkage Study of Modifiers of LRRK2-Related Parkinson's Disease
    Latourelle, Jeanne C.
    Hendricks, Audrey E.
    Pankratz, Nathan
    Wilk, Jemma B.
    Halter, Cheryl
    Nichols, William C.
    Gusella, James F.
    Destefano, Anita L.
    Myers, Richard H.
    Foroud, Tatiana
    MOVEMENT DISORDERS, 2011, 26 (11) : 2039 - 2044